Maple Securities USA’s Pfizer PFE Stock Holding History

Maple Securities USA’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-39,608	Closed	-$1.18M	–	28
2015 Q3	$1.18M	Sell	39,608 -978	-2%	-$31.4K	0.15%	29
2015 Q2	$1.29M	Sell	40,586 -66,908	-62%	-$2.18M	0.12%	59
2015 Q1	$3.55M	Sell	107,494 -630,786	-85%	-$20.1M	0.3%	36
2014 Q4	$21.8M	Buy	738,280 +9,803	+1%	+$281K	1.72%	4
2014 Q3	$20.4M	Buy	728,477 +539,897	+286%	+$15.2M	2.24%	5
2014 Q2	$5.31M	Sell	188,580 -108,037	-36%	-$3.08M	0.59%	12
2014 Q1	$9.04M	Buy	296,617 +256,667	+642%	+$7.65M	0.8%	10
2013 Q4	$1.16M	Sell	39,950 -426,599	-91%	-$12.4M	0.08%	101
2013 Q3	$12.7M	Buy	466,549 +55,337	+13%	+$1.51M	1.01%	15
2013 Q2	$10.9M	Buy	+411,212	New	+$11.4M	1%	10

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Maple Securities USA's PFE Position: Q4 2015 in Review

Maple Securities USA sold out of Pfizer (PFE) in Q4 2015, closing a stake of 39,608 shares — an estimated $1.18M sold.

Maple Securities USA first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $21.8M in Q4 2014. 1,969 funds tracked by Wall St. Rank hold PFE as of Q4 2015.

Maple Securities USA reported no remaining Pfizer position as of Q4 2015 after selling out during the quarter.
Maple Securities USA sold 39,608 Pfizer shares in Q4 2015, an estimated $1.18M.
Maple Securities USA first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
Maple Securities USA's Pfizer position peaked at $21.8M in Q4 2014.
1,969 funds tracked by Wall St. Rank held Pfizer as of Q4 2015.

Based on Maple Securities USA's 13F filing for Q4 2015, filed 15 Jan 2016.